Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
22M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
3.61M
-
Shares change
-
-376K
-
Total reported value, excl. options
-
$44.7M
-
Value change
-
-$5.87M
-
Number of buys
-
17
-
Number of sells
-
-14
-
Price
-
$12.40
Significant Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q2 2020
37 filings reported holding XGN - EXAGEN INC. - Common Stock, par value $0.001 per share as of Q2 2020.
EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.61M shares
of 22M outstanding shares and own 16.37% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (1.26M shares), WASATCH ADVISORS INC (618K shares), COWEN AND COMPANY, LLC (432K shares), VANGUARD GROUP INC (315K shares), BlackRock Inc. (234K shares), GOLDMAN SACHS GROUP INC (192K shares), VICTORY CAPITAL MANAGEMENT INC (81K shares), GEODE CAPITAL MANAGEMENT, LLC (78.9K shares), Russell Investments Group, Ltd. (78.6K shares), and NORTHERN TRUST CORP (60.3K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.